Biology Reference
In-Depth Information
22. Kennedy MA, Parks RJ (2009) Adenovirus
virion stability and the viral genome: size mat-
ters. Mol Ther 17:1664-1666
23. Prill J-M, Espenlaub S, Samen U, Engler T,
Schmidt E, Vetrini F et al (2011) Modifi cations
of adenovirus hexon allow for either hepato-
cyte detargeting or targeting with potential
evasion from Kupffer cells. Mol Ther
19:83-92
24. Guse K, Suzuki M, Sule G, Bertin TK,
Tyynismaa H, Ahola-Erkkilä S et al (2012)
Capsid-modifi ed adenoviral vectors for
improved muscle-directed gene therapy. Hum
Gene Ther 23:1065-1070
25. Kreppel F, Biermann V, Kochanek S, Schiedner
G (2002) A DNA-based method to assay total
and infectious particle contents and helper virus
contamination in high-capacity adenoviral vector
preparations. Hum Gene Ther 13:1151-1156
26. Palmer DJ, Ng P (2004) Physical and infec-
tious titers of helper-dependent adenoviral
vectors: a method of direct comparison to the
adenovirus reference material. Mol Ther
10:792-798
